Antidiuretic hormone antagonist to reduce cystine stone formation

Annals of Internal Medicine

Volumn 157, Issue 6, 2012, Pages 459-460

  de Boer, Hans ^a   Roelofsen, Anita ^a   Janssens, Pim M W ^a  

^a RIJNSTATE HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; CYSTINE; TIOPRONIN; TOLVAPTAN;

ADULT; ALKALINITY; CASE REPORT; CYSTINOSIS; CYSTINURIA; DIETARY INTAKE; DRUG WITHDRAWAL; FEMALE; FLUID INTAKE; FRAIL ELDERLY; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; LETTER; MALE; NEPHROLITHIASIS; NOCTURIA; PRIORITY JOURNAL; RASH; STONE FORMATION; URINARY EXCRETION; URINARY TRACT OBSTRUCTION; URINE VOLUME;

EID: 84868335855     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-157-6-201209180-00023     Document Type: Letter

References (3)

1. Mattoo A, Goldfarb DS. Cystinuria. Semin Nephrol. 2008;28:181-91. [PMID:18359399]
2. Decaux G, Soupart A, Vassart G. Non-peptide arginine-vasopressin antagonists: the vaptans. Lancet. 2008;371:1624-32. [PMID: 18468546]
3. Doggrell SA. Tolvaptan (Otsuka). Curr Opin Investig Drugs. 2004;5:977-83. [PMID: 15503654]